Skip to main content
Erschienen in: Clinical Rheumatology 4/2021

28.09.2020 | Original Article

Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain

verfasst von: Maria de Fátima Rodrigues Diniz, Katia Tomie Kozu, Adriana Maluf Elias, Alessandro Cavalcanti Lianza, Karen Saori Shiraishi Sawamura, Carolina Rocha Brito Menezes, Juliana Caires de Oliveira Achili Ferreira, Clovis Artur Silva, Gabriela Nunes Leal

Erschienen in: Clinical Rheumatology | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aimed to investigate subclinical left ventricle (LV) systolic dysfunction in juvenile dermatomyositis (JDM) using two-dimensional speckle-tracking echocardiography (2DST). Possible associations between LV deformation impairment and disease activity/cumulative damage were also evaluated.

Methods

Thirty-five consecutive JDM patients without cardiac symptoms and 35 healthy volunteers were enrolled. Clinical data were collected from medical records, and echocardiograms were performed by a pediatric cardiologist, unaware of patients’ conditions.

Results

Patients and controls had similar age (12.6 ± 0.7 vs.12.5 ± 0.6; p = 0.97) and gender (11F:24M vs.11F:24M; p = 1.0). Median of JDM duration was 4.6 (0.04–17.6) years, and only 6/35 (17%) had active disease (disease activity score (DAS > 3)). Conventional echocardiogram revealed preserved LV ejection fraction (EF) (≥ 55%) in all individuals. In JDM, 2DST identified reduction of LV longitudinal [−22(−17.2 to −27.9) % vs. −23(−20.8 to −27.4) %; p = 0.028)] and circumferential −23.9 ± 2.8% vs. −26.7 ± 2.9%; p = 0.0002) strain. Lower longitudinal strain was associated with DAS >3 −19.9(−17.2 to −26.5)% vs. −22.1−18.9 to −27.9)%; p = 0.046], MDI extent > 0 [−19(−17.2 to −22.5)% vs. −22.1−19.2 to −27.9)%; p = 0.0008], MDI severity > 0 [−19(−17.2 to −22.1)% vs. −22.3(−20.3 to −27.9)%; p = 0.0001] and calcinosis[−20.6(−17.2 to −23)% vs. −22.3(−20.3 to −27.9)%; p = 0.03]. Lower circumferential strain was associated with MDI extent > 0 (−22.1 ± 3.87% vs. −24.4 ± 2.3%; p = 0.039), MDI severity > 0 (−21.7 ± 3% vs. 24.7 ± 2.3%; p = 0.004) and calcinosis (−22.5 ± 3.3% vs. −24.8 ± 2.1%; p = 0.02). There was a negative correlation between longitudinal strain and cumulative dose of prednisone (r = −0.44; p = 0.009) and methotrexate (r = −0.33; p = 0.0008).

Conclusions

LV 2DST detected early systolic myocardial compromise in asymptomatic pediatric JDM patients, with preserved EF. Longitudinal strain impairment was associated with disease activity and cumulative damage, whereas circumferential strain impairment was associated exclusively with cumulative damage.
Key Points:
• Serious cardiac involvement is rare but has been associated with death in juvenile dermatomyositis.
• Two-dimensional speckle tracking stands out for the identification of subclinical myocardial compromise in juvenile dermatomyositis.
• Longitudinal strain impairment is associated with disease activity and cumulative damage, whereas circumferential strain impairment is associated exclusively with cumulative damage.
Literatur
1.
Zurück zum Zitat Rider LG, Lindsley CB, Miller FW (2016) Juvenile dermatomyositis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR (eds) Textbook of Pediatric Rheumatology, 7th edn. Elsevier, Philadelphia, pp 351–383CrossRef Rider LG, Lindsley CB, Miller FW (2016) Juvenile dermatomyositis. In: Petty RE, Laxer RM, Lindsley CB, Wedderburn LR (eds) Textbook of Pediatric Rheumatology, 7th edn. Elsevier, Philadelphia, pp 351–383CrossRef
3.
Zurück zum Zitat Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U, Felix SB, Garcia-Pavia P, Hachulla E, Heymans S, Imazio M, Klingel K, Marcolongo R, Matucci Cerinic M, Pantazis A, Plein S, Poli V, Rigopoulos A, Seferovic P, Shoenfeld Y, Zamorano JL, Linhart A (2017) Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 38(35):2649–2662. https://doi.org/10.1093/eurheartj/ehx321CrossRefPubMed Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U, Felix SB, Garcia-Pavia P, Hachulla E, Heymans S, Imazio M, Klingel K, Marcolongo R, Matucci Cerinic M, Pantazis A, Plein S, Poli V, Rigopoulos A, Seferovic P, Shoenfeld Y, Zamorano JL, Linhart A (2017) Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 38(35):2649–2662. https://​doi.​org/​10.​1093/​eurheartj/​ehx321CrossRefPubMed
8.
Zurück zum Zitat Dulcan M (1994) Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th edn. Little, Brown & Co, Boston, pp 253–256 Dulcan M (1994) Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 9th edn. Little, Brown & Co, Boston, pp 253–256
9.
Zurück zum Zitat Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD et al (2004) Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 50:1595–1603. https://doi.org/10.1002/art.20179CrossRefPubMed Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD et al (2004) Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 50:1595–1603. https://​doi.​org/​10.​1002/​art.​20179CrossRefPubMed
11.
Zurück zum Zitat Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 63(Suppl 11):S118–S157. https://doi.org/10.1002/acr.20532CrossRef Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 63(Suppl 11):S118–S157. https://​doi.​org/​10.​1002/​acr.​20532CrossRef
12.
Zurück zum Zitat Apaz MT, Saad-Magalhães C, Pistorio A, Ravelli A, Sato JO, Marcantoni MB, Meiorin S, Filocamo G, Pilkington C, Maillard S, Al-Mayouf S, Prahalad S, Fasth A, Joos R, Schikler K, Mozolova D, Landgraf JM, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (2009) Health-related quality of life of patients with juvenile dermatomyositis: results from the paediatric rheumatology international trials organisation multinational quality of life cohort study. Arthritis Rheum 6:509–517. https://doi.org/10.1002/art.24343CrossRef Apaz MT, Saad-Magalhães C, Pistorio A, Ravelli A, Sato JO, Marcantoni MB, Meiorin S, Filocamo G, Pilkington C, Maillard S, Al-Mayouf S, Prahalad S, Fasth A, Joos R, Schikler K, Mozolova D, Landgraf JM, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (2009) Health-related quality of life of patients with juvenile dermatomyositis: results from the paediatric rheumatology international trials organisation multinational quality of life cohort study. Arthritis Rheum 6:509–517. https://​doi.​org/​10.​1002/​art.​24343CrossRef
13.
Zurück zum Zitat Klatchoian DA, Len CA, Terreri MT, Silva M, Itamoto C, Ciconelli RM, Varni JW, Hilário MO (2008) Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory version 4.0 Generic Core Scales. J Pediatr 84:308–315. https://doi.org/10.2223/JPED.1788CrossRef Klatchoian DA, Len CA, Terreri MT, Silva M, Itamoto C, Ciconelli RM, Varni JW, Hilário MO (2008) Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory version 4.0 Generic Core Scales. J Pediatr 84:308–315. https://​doi.​org/​10.​2223/​JPED.​1788CrossRef
16.
Zurück zum Zitat Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, Lai WW, Geva T (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the pediatric measurements writing group of the American society of echocardiography pediatric and congenital heart disease council. J Am Soc Echocardiogr 23:465–495. https://doi.org/10.1016/j.echo.2010.03.019CrossRefPubMed Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK, Lai WW, Geva T (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the pediatric measurements writing group of the American society of echocardiography pediatric and congenital heart disease council. J Am Soc Echocardiogr 23:465–495. https://​doi.​org/​10.​1016/​j.​echo.​2010.​03.​019CrossRefPubMed
17.
Zurück zum Zitat Mor-Avi V, Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL (2011) Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 24:277–313. https://doi.org/10.1016/j.echo.2011.01.015CrossRefPubMed Mor-Avi V, Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, Sicari R, Smiseth OA, Smulevitz B, Takeuchi M, Thomas JD, Vannan M, Voigt JU, Zamorano JL (2011) Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography. J Am Soc Echocardiogr 24:277–313. https://​doi.​org/​10.​1016/​j.​echo.​2011.​01.​015CrossRefPubMed
18.
19.
26.
Zurück zum Zitat Rosa Neto NS, Goldenstein-Schainberg C (2010) Juvenile dermatomyositis: review and update of the pathogenesis and treatment. Rev Bras Reumatol 50:299–312CrossRefPubMed Rosa Neto NS, Goldenstein-Schainberg C (2010) Juvenile dermatomyositis: review and update of the pathogenesis and treatment. Rev Bras Reumatol 50:299–312CrossRefPubMed
27.
Zurück zum Zitat Bottai M, Tjärnlund A, Santoni G, The International Myositis Classification Criteria Project consortium, the Euromyositis register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) et al (2017) EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open 3:e000507. https://doi.org/10.1136/rmdopen-2017-000507CrossRefPubMedPubMedCentral Bottai M, Tjärnlund A, Santoni G, The International Myositis Classification Criteria Project consortium, the Euromyositis register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) et al (2017) EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open 3:e000507. https://​doi.​org/​10.​1136/​rmdopen-2017-000507CrossRefPubMedPubMedCentral
Metadaten
Titel
Echocardiographic study of juvenile dermatomyositis patients: new insights from speckle-tracking-derived strain
verfasst von
Maria de Fátima Rodrigues Diniz
Katia Tomie Kozu
Adriana Maluf Elias
Alessandro Cavalcanti Lianza
Karen Saori Shiraishi Sawamura
Carolina Rocha Brito Menezes
Juliana Caires de Oliveira Achili Ferreira
Clovis Artur Silva
Gabriela Nunes Leal
Publikationsdatum
28.09.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 4/2021
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05418-4

Weitere Artikel der Ausgabe 4/2021

Clinical Rheumatology 4/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.